|
Delayed
OTC Markets
22:52:15 24/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0500 USD | 0.00% |
|
+25.00% | +150.00% |
| Market Cap | 5.07M 3.65M 3.13M 2.94M 2.69M 348M 5.09M 34.79M 13.48M 176M 13.7M 13.41M 582M | P/E 2024 |
-6.82x | P/E 2025 | -2.84x |
|---|---|---|---|---|---|
| Enterprise Value | 9.47M 6.82M 5.85M 5.49M 5.02M 650M 9.51M 64.99M 25.19M 328M 25.59M 25.04M 1.09B | EV / Sales 2024 |
1.15x | EV / Sales 2025 | 0.85x |
| Free-Float |
89.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | +25.00% | ||
| Current month | +1.21% | ||
| 1 month | +73.61% | ||
| 3 months | -23.08% | ||
| 6 months | +67.79% | ||
| Current year | +150.00% |
| 1 week | 0.02 | 0.05 | |
| 1 month | 0.02 | 0.05 | |
| Current year | 0 | 0.07 | |
| 1 year | 0 | 0.07 | |
| 3 years | 0 | 0.15 | |
| 5 years | 0 | 0.4 | |
| 10 years | 0 | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Taz Turner
CEO | Chief Executive Officer | - | 22/09/2017 |
Ashish Kapoor
DFI | Director of Finance/CFO | 48 | 10/03/2015 |
Graeme Hawkins
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Taz Turner
CHM | Chairman | - | 17/05/2018 |
Benjamin Higham
BRD | Director/Board Member | - | 08/04/2020 |
Jakob Ripshtein
BRD | Director/Board Member | 60 | 08/04/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/12/23 | Buy | Director | 30,000 | 0.0274% | ||
| 17/12/23 | Buy | Director | 500 | 0.0005% | ||
| 17/12/23 | Buy | Director | 500 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +25.00% | -28.47% | -60.85% | 5.49M | ||
| -0.85% | -0.19% | -15.30% | +13.08% | 1.67B | ||
| +1.23% | +5.36% | +24.03% | +183.89% | 955M | ||
| -0.28% | +4.13% | -26.76% | +105.23% | 225M | ||
| -2.30% | +2.41% | -46.20% | -63.83% | 194M | ||
| -2.90% | +3.32% | -36.10% | +40.57% | 101M | ||
| -2.67% | -0.34% | +46.73% | -41.83% | 87.31M | ||
| Average | -1.13% | +6.30% | -11.73% | +25.18% | 461.97M | |
| Weighted average by Cap. | -0.40% | +6.31% | -5.34% | +64.54% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 13.8M 9.94M 8.53M 8M 7.31M 948M 13.86M 94.73M 36.71M 478M 37.31M 36.5M 1.58B | 14.25M 10.26M 8.81M 8.27M 7.55M 979M 14.32M 97.83M 37.91M 494M 38.53M 37.69M 1.64B |
| Net income | -1.49M -1.07M -923K -866K -791K -103M -1.5M -10.25M -3.97M -51.72M -4.04M -3.95M -171M | -2.69M -1.94M -1.66M -1.56M -1.43M -185M -2.7M -18.47M -7.16M -93.24M -7.28M -7.12M -309M |
| Net Debt | 5.66M 4.07M 3.5M 3.28M 3M 389M 5.69M 38.85M 15.05M 196M 15.3M 14.97M 649M | 4.4M 3.17M 2.72M 2.55M 2.33M 302M 4.42M 30.19M 11.7M 152M 11.89M 11.63M 505M |
Employees
-
Sector
Drug Retailers
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/08/26 | $0.0500 | 0.00% | 14,140 |
| 21/08/26 | $0.0500 | 0.00% | 2,790 |
- Stock Market
- Stocks
- LVRLF Stock
Select your edition
All financial news and data tailored to specific country editions
















